Influenza, commonly known as the flu, is a highly contagious respiratory illness caused by influenza viruses. For most ...

CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its ...

It's not the actual flu, and it's rarely serious. But when thousands of students arrive on campus they bring with them a cocktail of respiratory viruses. Add packed lecture theatres, dirty shared ...

It's not an actual flu, and it's rarely serious, but when thousands of students arrive on campus they bring a cocktail of ...

Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company applying its proprietary Cloudbreak® platform to develop ...

Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop ...

JP Morgan initiated coverage on Cidara Therapeutics with Overweight rating & tgt of $200, citing lead flu asset CD388's ...

Influenza is an infectious disease of the mouth, nose and upper airways caused by a flu virus. In Europe, during the 15th and 16th centuries, people believed flu epidemics were influenced by the ...

“The care I got was brilliant, absolutely fantastic, I wouldn’t be here without all their help.” Dr Benson has expressed his ...

CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, Octobe ...

Cidara’s lead candidate, CD388, is a long-acting antiviral prophylactic designed for universal prevention of seasonal and ...

Cidara Therapeutics Inc (NASDAQ:CDTX) shares are trading higher on Friday after the biotech company made a recent ...